Literature DB >> 21717786

[Selenium and cancer: from prevention to treatment].

J Brozmanová1.   

Abstract

Selenium (Se) is an essential dietary component for all animals, including human beings, that is regarded as a protective agent against cancer. Although the mode of its anticancer action is not yet fully understood, several mechanisms, such as antioxidant protection through selenoenzymes, stimulation of DNA repair, and apoptosis in tumor prestages have all been proposed. Despite the unsupported results of the last "SELECT" trial, the cancer-preventing activity of Se has been demonstrated in a majority of epidemiological studies. Moreover, recent studies suggest that Se has a potential to be used not only in cancer prevention but also in cancer treatment, where in combination with other anticancer drugs or radiation it may increase the efficacy of cancer therapy. In combating cancer cells, Se acts as a prooxidant rather than an antioxidant, inducing apoptosis through the generation of oxidative stress. Thus, inorganic Se compounds, having high redox potency, represent a promising option in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717786

Source DB:  PubMed          Journal:  Klin Onkol        ISSN: 0862-495X


  4 in total

Review 1.  Prevention and treatment of cancers by immune modulating nutrients.

Authors:  Naveena B Janakiram; Altaf Mohammed; Venkateshwar Madka; Gaurav Kumar; Chinthalapally V Rao
Journal:  Mol Nutr Food Res       Date:  2016-03-09       Impact factor: 5.914

2.  Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells.

Authors:  Junzhang Zhao; Rui Zhou; Kaiyuan Hui; Yang Yang; QiuYue Zhang; Yali Ci; Lei Shi; Caimin Xu; Fang Huang; Yu Hu
Journal:  Oncotarget       Date:  2017-03-21

3.  PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.

Authors:  H Luo; Y Yang; J Duan; P Wu; Q Jiang; C Xu
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

4.  The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.

Authors:  P Wu; K J Shi; J J An; Y L Ci; F Li; K Y Hui; Y Yang; C M Xu
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.